Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

por Jia, Shuangshuang, Bi, Lei, Chu, Yuping, Liu, Xiao, Feng, Juan, Xu, Li, Zhang, Tao, Gu, Hongtao, Yang, Lan, Bai, Qingxian, Liang, Rong, Tian, Biao, Gao, Yaya, Tang, Hailong, Gao, Guangxun
Publicado 2022

Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens

por Liu, Xiao, Jia, Shuangshuang, Chu, Yuping, Tian, Biao, Gao, Yaya, Zhang, Chunyan, Zheng, Yanhua, Jia, Weijing, Liu, Xiangxiang, Yuan, Ruifeng, Zhang, Na, Feng, Juan, Dong, Hongjuan, Xin, Xiaoli, Chang, Ziwei, Cao, Zhengcong, Tang, Hailong, Gao, Guangxun
Publicado 2022